News
ATRC
38.23
+2.30%
0.86
ATRICURE INC <ATRC.O>: UBS CUTS TARGET PRICE TO $50 FROM $55
Reuters · 1h ago
AtriCure price target lowered to $50 from $55 at UBS
TipRanks · 3h ago
Atricure (ATRC) Gets a Buy from UBS
TipRanks · 3h ago
U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit
Reuters · 8h ago
Atricure Still Faces Broad, Evolving Risks Despite No Material Changes in 2025 10-K Disclosures
TipRanks · 9h ago
Inspire Medical Systems appoints AtriCure CEO Michael Carrel to board
PUBT · 1d ago
AtriCure to join Needham Virtual MedTech & Diagnostics investor conference
PUBT · 1d ago
Weekly Report: what happened at ATRC last week (0720-0724)?
Weekly Report · 1d ago
Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF) and Atricure (ATRC)
TipRanks · 1d ago
AtriCure to Participate at Upcoming Investor Conferences
Barchart · 1d ago
Atricure Earnings Call Signals Profitable Growth Momentum
TipRanks · 3d ago
Inspire Medical names AtriCure CEO Michael Carrel to board
PUBT · 3d ago
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Atricure (ATRC)
TipRanks · 4d ago
AtriCure releases transcript of Q2 2026 earnings call
PUBT · 4d ago
Atricure (ATRC) Receives a Buy from Stifel Nicolaus
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Prime Medicine, Inc. (PRME) and Community Health (CYH)
TipRanks · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Atricure (ATRC) and Medpace Holdings (MEDP)
TipRanks · 4d ago
Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Atricure (ATRC)
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Otsuka Holdings Co (OtherOTSKF) and Atricure (ATRC)
TipRanks · 4d ago
AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say
NASDAQ · 4d ago
More
Webull provides a variety of real-time ATRC stock news. You can receive the latest news about Atricure through multiple platforms. This information may help you make smarter investment decisions.
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.